Trial Profile
A Prospective, Randomised study to evaluate the efficacy and safety of flecainide and metoprolol in preventing clinical recurrences of Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs Flecainide (Primary) ; Metoprolol (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 01 Aug 2017 New trial record